SNDL Inc. (SNDL)
USD 1.7
(-2.86%)
USD 1.7
(-2.86%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 353.23 Million CAD | 44.17% |
| 2022 | 201.64 Million CAD | 232.14% |
| 2021 | 60.71 Million CAD | 28.08% |
| 2020 | 47.4 Million CAD | -52.29% |
| 2019 | 99.34 Million CAD | 797.7% |
| 2018 | 11.06 Million CAD | 623.97% |
| 2017 | 1.52 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 69.98 Million CAD | 5.53% |
| 2024 Q1 | 66.31 Million CAD | -9.49% |
| 2023 Q4 | 73.26 Million CAD | 1.08% |
| 2023 FY | 290.71 Million CAD | 44.17% |
| 2023 Q1 | 70.77 Million CAD | -0.96% |
| 2023 Q2 | 74.18 Million CAD | 4.82% |
| 2023 Q3 | 72.48 Million CAD | -2.3% |
| 2022 Q2 | 53.05 Million CAD | 215.21% |
| 2022 Q1 | 16.83 Million CAD | 0.94% |
| 2022 Q4 | 71.46 Million CAD | 18.5% |
| 2022 Q3 | 60.3 Million CAD | 13.67% |
| 2022 FY | 201.64 Million CAD | 232.14% |
| 2021 Q3 | 15.79 Million CAD | -10.39% |
| 2021 FY | 60.71 Million CAD | 28.08% |
| 2021 Q4 | 16.67 Million CAD | 5.55% |
| 2021 Q2 | 17.62 Million CAD | 66.12% |
| 2021 Q1 | 10.61 Million CAD | -9.29% |
| 2020 FY | 47.4 Million CAD | -52.29% |
| 2020 Q4 | 11.69 Million CAD | 32.54% |
| 2020 Q3 | 8.82 Million CAD | -22.92% |
| 2020 Q2 | 11.45 Million CAD | -44.04% |
| 2020 Q1 | 20.46 Million CAD | -31.72% |
| 2019 FY | 99.34 Million CAD | 797.7% |
| 2019 Q4 | 29.96 Million CAD | 11.34% |
| 2019 Q2 | 23.33 Million CAD | 22.02% |
| 2019 Q1 | 19.12 Million CAD | -45.32% |
| 2019 Q3 | 26.91 Million CAD | 15.34% |
| 2018 FY | 11.06 Million CAD | 623.97% |
| 2018 Q1 | 6.87 Million CAD | 0.0% |
| 2018 Q3 | 6.77 Million CAD | 25.04% |
| 2018 Q4 | 34.98 Million CAD | 416.24% |
| 2018 Q2 | 5.41 Million CAD | -21.2% |
| 2017 FY | 1.52 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Theratechnologies Inc. | 72.75 Million USD | -385.504% |
| Harrow Health, Inc. | 89.97 Million USD | -292.599% |
| Dynavax Technologies Corporation | 219.14 Million USD | -61.187% |
| Biofrontera Inc. | 39.95 Million USD | -783.989% |
| Cronos Group Inc. | 96.7 Million USD | -265.253% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -3639.498% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | -52.174% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -802.186% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 3794.519% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | -720.698% |
| Radius Health, Inc. | 265.92 Million USD | -32.83% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -2451.91% |
| DURECT Corporation | 43.71 Million USD | -708.036% |
| ProPhase Labs, Inc. | 37.85 Million USD | -833.195% |
| Safety Shot Inc | 12.1 Million USD | -2816.944% |
| Phibro Animal Health Corporation | 260.29 Million USD | -35.703% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -11409.005% |
| Alvotech | 285.43 Million USD | -23.751% |
| Assertio Holdings, Inc. | 368.58 Million USD | 4.165% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 33.228% |
| Rockwell Medical, Inc. | 15.37 Million USD | -2197.6% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -2591.408% |
| Procaps Group S.A. | 187.24 Million USD | -88.647% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 40.131% |
| SCYNEXIS, Inc. | 51.84 Million USD | -581.286% |
| Aytu BioPharma, Inc. | 59.84 Million USD | -490.296% |
| Viatris Inc. | 5.96 Billion USD | 94.079% |
| OptiNose, Inc. | 85.1 Million USD | -315.07% |
| SIGA Technologies, Inc. | 22.04 Million USD | -1502.471% |
| Tilray Brands, Inc. | 251.35 Million USD | -40.53% |
| PetIQ, Inc. | 192.72 Million USD | -83.283% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -2591.408% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 77.875% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -3530.038% |
| Alimera Sciences, Inc. | 62.64 Million USD | -463.901% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | -121.869% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -46226.125% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -5901.678% |
| Organogenesis Holdings Inc. | 314.13 Million USD | -12.447% |
| Journey Medical Corporation | 54.59 Million USD | -547.018% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -1883.504% |
| Alpha Teknova, Inc. | 45.85 Million USD | -670.259% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | -1568.633% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | -620.325% |
| PainReform Ltd. | 9.58 Million USD | -3585.653% |
| Cosmos Health Inc. | 26.18 Million USD | -1249.207% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | -114.125% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -3495.247% |
| Embecta Corp. | 528.4 Million USD | 33.15% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -8750.433% |
| Talphera, Inc. | 11.99 Million USD | -2845.081% |
| Pacira BioSciences, Inc. | 326.37 Million USD | -8.229% |
| Incannex Healthcare Limited | 30.05 Million USD | -1075.367% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -1578.697% |
| Shineco, Inc. | 17.94 Million USD | -1868.087% |
| Procaps Group, S.A. | 199.47 Million USD | -77.08% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | -80.237% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | -687.517% |
| Lantheus Holdings, Inc. | 344.9 Million USD | -2.416% |
| Alvotech | 285.43 Million USD | -23.751% |
| Hempacco Co., Inc. | 7.59 Million USD | -4549.975% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | -151.029% |
| Bright Green Corporation | 8.25 Million USD | -4180.122% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | -29.914% |
| Kamada Ltd. | 45.42 Million USD | -677.601% |
| Indivior PLC | 911 Million USD | 61.226% |
| Evoke Pharma, Inc. | 12.4 Million USD | -2746.44% |
| Flora Growth Corp. | 10.57 Million USD | -3239.002% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -1578.697% |
| Evolus, Inc. | 189.75 Million USD | -86.148% |
| HUTCHMED (China) Limited | 436.23 Million USD | 19.026% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | -129.173% |
| Akanda Corp. | 3.48 Million USD | -10040.152% |